LONDON, April 22, 2014 /PRNewswire/ --
The trading session on Monday, April 21, 2014 ended on a higher note as the S&P 500 finished the session 0.38% higher at 1,871.89 and the NASDAQ Composite closed at 4,121.55, up 0.64%. The Dow Jones Industrial Average finished at 16,449.25, up 0.25%. During the session, the eight out of ten sectors ended in positive. The S&P 500 Health Care Sector Index closed the day at 666.48, up 1.20%, and the same has advanced 1.75% in the previous three trading sessions. Investor-Edge has initiated coverage on the following equities: Rockwell Medical Inc. (NASDAQ: RMTI), Stryker Corp. (NYSE: SYK), Baxter International Inc. (NYSE: BAX) and Covidien PLC (NYSE: COV). Free technical research on RMTI, SYK, BAX and COV can be downloaded upon signing up at:
On Monday, Shares in Rockwell Medical Inc. fluctuated between $9.81 and $10.55 before ending the session 1.65% higher at $10.16. The company's stock reported a trading volume of 0.65 million shares, which is at par with its three months average volume. The company's shares have plummeted 4.83% in the previous three trading sessions, 27.26% in the last one month, and 2.73% on YTD basis. The stock is trading below its 50-day and 200-day moving averages of $12.26 and $10.29, respectively. Additionally, the stock has a Relative Strength Index (RSI) of 33.47. Sign up today to read free research on RMTI at:
Stryker Corp.'s stock advanced 0.89%, to close the day at $79.48. The stock recorded a trading volume of 2.07 million shares, much above its three months average volume of 1.70 million shares. Shares of the company traded at a PE ratio of 18.96. The stock oscillated between $78.80 and $79.73 during the trading session. Stryker Corp.'s shares have gained 1.13% in the previous three months, but the same has edged 0.11% lower in the last three trading sessions. The stock has advanced 5.78% since the start of this year. The stock is trading above its 200-day moving average of $74.31. Moreover, shares of the company have an RSI of 40.31. Sign up today to read free research on SYK at:
Baxter International Inc.'s stock finished the Monday's session 0.47% higher at $73.15. A total of 2.33 million shares were traded, which was below its three months average volume of 3.64 million shares. The stock moved between $72.47 and $73.29 during the trading session. Over the last one month and previous three months, Baxter International Inc.'s shares have advanced 8.03% and 5.16%, respectively. Also, since the beginning of this year, the company's stock has gained an upside of 5.18%. The company's shares are trading above its 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $69.80 is greater than its 200-day moving average of $69.27. Baxter International Inc.'s stock has an RSI of 58.98. Sign up today to read free research on BAX at:
On Monday, Shares in Covidien PLC recorded a trading volume of 1.84 million shares, lower than its three months average volume of 2.26 million shares. The stock ended the day at $70.67, which was 1.16% above its previous day's closing price of $69.86, and registered an intraday range of $69.98 and $70.78. Covidien PLC's shares have gained 1.10% in the previous three trading sessions, 3.64% in the last three months, and 3.77% on YTD basis. The company's stock is trading above its 200-day moving average of $65.66. Furthermore, the shares of the company traded at a PE ratio of 17.92 and have an RSI of 44.91. Sign up today to read free research on COV at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.